The cat as a model for human obesity and diabetes

Journal of Diabetes Science and Technology

Volumn 6, Issue 3, 2012, Pages 525-533

  Hoenig, Margarethe ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Amyloid; Glucose tolerance; Insulin sensitivity; Metabolic syndrome

Indexed keywords

ADIPONECTIN; AMYLOID; FATTY ACID; GLUCOSE; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; ANTIDIABETIC AGENT;

ADIPOSE TISSUE; ATHEROSCLEROSIS; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE COURSE; FATTY ACID BLOOD LEVEL; FELINE MODEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; METABOLIC REGULATION; METABOLIC SYNDROME X; MUSCLE TISSUE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; POSTPRANDIAL STATE; REDUCTION; RISK FACTOR; TISSUE SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ANIMAL DISEASE; BLOOD; CAT; CAT DISEASE; DISEASE MODEL; METABOLISM; PATHOPHYSIOLOGY; REVIEW; SPECIES DIFFERENCE;

ANIMALS; BLOOD GLUCOSE; CAT DISEASES; CATS; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; OBESITY; RISK FACTORS; SPECIES SPECIFICITY;

EID: 84872391000     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681200600306     Document Type: Conference Paper

References (79)

1. Courcier EA, O'Higgins R, Mellor DJ, Yam PS. Prevalence and risk factors for feline obesity in a first opinion practice in Glasgow, Scotland. J Feline Med Surg. 2010;12(10):746-53.
2. Scarlett JM, Donoghue S. Associations between body condition and disease in cats. J Am Vet Med Assoc. 1998;212(11):1725-31. (Pubitemid 128472413)
3. Laflamme D. Development and validation of a body condition score system for cats: a clinical tool. Feline Pract. 1997;25(5-6):13-8. (Pubitemid 127154586)
4. Nelson RW, Himsel CA, Feldman EC, Bottoms GD. Glucose tolerance and insulin response in normal-weight and obese cats. Am J Vet Res. 1990;51(9):1357-62. (Pubitemid 20326493)
5. Hawthorne A, Butterwick R. Predicting the body composition of cats: development of a zoometric measurement for estimation of percentage body fat in cats. J Vet Intern Med. 2000;14(3):365.
6. Wilkins C, Long RC Jr, Waldron M, Ferguson DC, Hoenig M. Assessment of the influence of fatty acids on indices of insulin sensitivity and myocellular lipid content by use of magnetic resonance spectroscopy in cats. Am J Vet Res. 2004;65(8):1090-9. (Pubitemid 39136631)
7. Hoenig M, Thomaseth K, Waldron M, Ferguson DC. Insulin sensitivity, fat distribution, and adipocytokine response to diferent diets in lean and obese cats before and after weight loss. Am J Physiol Regul Integr Comp Physiol. 2007;292(1):R227-34. (Pubitemid 46089834)
8. Speakman JR, Booles D, Butterwick R. Validation of dual energy X-ray absorptiometry (DXA) by comparison with chemical analysis of dogs and cats. Int J Obes Relat Metab Disord. 2001;25(3):439-47. (Pubitemid 32209822)
9. Wagenknecht LE, Langefeld CD, Scherzinger AL, Norris JM, Hafner SM, Saad MF, Bergman RN. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes. 2003;52(10):2490-6. (Pubitemid 37210536)
10. Russell K, Sabin R, Holt S, Bradley R, Harper EJ. Influence of feeding regimen on body condition in the cat. J Small Anim Pract. 2000;41(1):12-7.
11. Prahl A, Guptill L, Glickman NW, Tetrick M, Glickman LT. Time trends and risk factors for diabetes mellitus in cats presented to veterinary teaching hospitals. J Feline Med Surg. 2007;9(5):351-8. (Pubitemid 47413036)
12. McCann TM, Simpson KE, Shaw DJ, Butt JA, Gunn-Moore DA. Feline diabetes mellitus in the UK: the prevalence within an insured cat population and a questionnaire-based putative risk factor analysis. J Feline Med Surg. 2007;9(4):289-99. (Pubitemid 47082276)
13. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-607. (Pubitemid 19004941)
14. Schrauwen-Hinderling VB, Hesselink MK, Schrauwen P, Kooi ME. Intramyocellular lipid content in human skeletal muscle. Obesity (Silver Spring). 2006;14(3):357-67. (Pubitemid 46219752)
15. Hoenig M, McGoldrick JB, deBeer M, Demacker PN, Ferguson DC. Activity and tissue-specific expression of lipases and tumor-necrosis factor alpha in lean and obese cats. Domest Anim Endocrinol. 2006;30(4):333-44.
16. Porat O. The efect of tumor necrosis factor alpha on the activity of lipoprotein lipase in adipose tissue. Lymphokine Res. 1989;8(4):459-69. (Pubitemid 19276997)
17. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest. 1995;95(5):2111-9.
18. Hoenig M, Ferguson DC. Effect of darglitazone on glucose clearance and lipid metabolism in obese cats. Am J Vet Res. 2003 Nov;64(11):1409-13. (Pubitemid 37407394)
19. Jones JG, Solomon MA, Sherry AD, Jefrey FM, Malloy CR. 13C NMR measurements of human gluconeogenic fluxes after ingestion of [U-13C]propionate, phenylacetate, and acetaminophen. Am J Physiol. 1998;275(5 Pt 1):E843-52.
20. Jin ES, Burgess SC, Merritt ME, Sherry AD, Malloy CR. Difering mechanisms of hepatic glucose overproduction in triiodothyronine-treated rats vs. Zucker diabetic fatty rats by NMR analysis of plasma glucose. Am J Physiol Endocrinol Metab. 2005;288(4):E654-62. (Pubitemid 40397199)
21. Burgess SC, Leone TC, Wende AR, Croce MA, Chen Z, Sherry AD, Malloy CR, Finck BN. Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha)-deficient mice. J Biol Chem. 2006;281(28):19000-8. (Pubitemid 44035403)
22. Kley S, Hoenig M, Glushka J, Jin ES, Burgess SC, Waldron M, Jordan ET, Prestegard JH, Ferguson DC, Wu S, Olson DE. The impact of obesity, sex, and diet on hepatic glucose production in cats. Am J Physiol Regul Integr Comp Physiol. 2009;296(4):R936-43.
23. Hoenig M, Jordan ET, Glushka J, Kley S, Patil A, Waldron M, Prestegard JH, Ferguson DC, Wu S, Olson DE. Efect of macronutrients, age, and obesity on 6 and 24-hour post-prandial glucose metabolism in cats. Am J Physiol Regul Integr Comp Physiol. 2011;301(6):R1798-807.
24. Kettelhut IC, Foss MC, Migliorini RH. Glucose homeostasis in a carnivorous animal (cat) and in rats fed a high-protein diet. Am J Physiol. 1980;239(5):R437-44. (Pubitemid 11254183)
25. Ballard FJ. Glucose utilization in mammalian liver. Comp Biochem Physiol. 1965;14:437-43.
26. Engelking LR. Textbook of veterinary physiological chemistry. 2nd ed. Burlington: Academic Press; 2011.
27. Rothman DL, Magnusson I, Katz LD, Shulman RG, Shulman GI. Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science. 1991;254(5031):573-6. (Pubitemid 21917377)
28. Hoenig M, Hall G, Ferguson D, Jordan K, Henson M, Johnson K, O'Brien T. A feline model of experimentally induced islet amyloidosis. Am J Pathol. 2000;157(6):2143-50.
29. Hull RL, Westermark GT, Westermark P, Kahn SE. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab. 2004;89(8):3629-43. (Pubitemid 39071447)
30. Martin LJ, Siliart B, Lutz TA, Biourge V, Nguyen P, Dumon HJ. Postprandial response of plasma insulin, amylin and acylated ghrelin to various test meals in lean and obese cats. Br J Nutr. 2010;103(11):1610-9.
31. Henson MS, Hegstad-Davies RL, Wang Q, Hardy RM, Armstrong PJ, Jordan K, Johnson KH, O'Brien TD. Evaluation of plasma islet amyloid polypeptide and serum glucose and insulin concentrations in nondiabetic cats classified by body condition score and in cats with naturally occurring diabetes mellitus. Am J Vet Res. 2011;72(8):1052-8.
32. Gal A, Hoenig M, O'Brien TD, Wallig M, Singh K. Histopathology from life-long dietary-induced obese cats and lean controls. Vet Pathol. 2010;47(6S):150(abstract).
33. Ma Z, Westermark GT, Johnson KH, O'Brien TD, Westermark P. Quantitative immunohistochemical analysis of islet amyloid polypeptide (IAPP) in normal, impaired glucose tolerant, and diabetic cats. Amyloid. 1998;5(4):255-61. (Pubitemid 128690764)
34. Nelson RW, Grifey SM, Feldman EC, Ford SL. Transient clinical diabetes mellitus in cats: 10 cases (1989-1991). J Vet Intern Med. 1999;13(1):28-35.
35. Dohan FC, Lukens FD. Experimental diabetes produced by the administration of glucose. Endocrinology. 1948;42(4):244-62.
36. Hoenig M, Thomaseth K, Brandao J, Waldron M, Ferguson DC. Assessment and mathematical modeling of glucose turnover and insulin sensitivity in lean and obese cats. Domest Anim Endocrinol. 2006;31(4):373-89. (Pubitemid 44528205)
37. Hoenig M, Thomaseth K, Waldron M, Ferguson DC. Fatty acid turnover, substrate oxidation, and heat production in lean and obese cats during the euglycemic hyperinsulinemic clamp. Domest Anim Endocrinol. 2007;32(4):329-38. (Pubitemid 46428045)
38. Petrus DJ, Jackson MW, Kemnitz JW, Finegood DT, Panciera D. Assessing insulin sensitivity in the cat: evaluation of the hyperinsulinemic euglycemic clamp and the minimal model analysis. Res Vet Sci. 1998;65(2):179-81. (Pubitemid 128515683)
39. Brennan CL, Hoenig M, Ferguson DC. GLUT4 but not GLUT1 expression decreases early in the development of feline obesity. Domest Anim Endocrinol. 2004;26(4):291-301. (Pubitemid 38448852)
40. Appleton DJ, Rand JS, Priest J, Sunvold GD. Determination of reference values for glucose tolerance, insulin tolerance, and insulin sensitivity tests in clinically normal cats. Am J Vet Res. 2001;62(4):630-6. (Pubitemid 33605786)
41. Backus RC, Cave NJ, Ganjam VK, Turner JB, Biourge VC. Age and body weight efects on glucose and insulin tolerance in colony cats maintained since weaning on high dietary carbohydrate. J Anim Physiol Anim Nutr (Berl). 2010;94(6):e318-28.
42. Brehm A, Thomaseth K, Bernroider E, Nowotny P, Waldhäusl W, Pacini G, Roden M. The role of endocrine counterregulation for estimating insulin sensitivity from intravenous glucose tolerance tests. J Clin Endocrinol Metab. 2006;91(6):2272-8. (Pubitemid 43855017)
43. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN. MINMOD millennium: a computer program to calculate glucose efectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther. 2003;5(6):1003-15. (Pubitemid 38009940)
44. Feldhahn JR, Rand JS, Martin G. Insulin sensitivity in normal and diabetic cats. J Feline Med Surg. 1999;1(2):107-15. (Pubitemid 129670297)
45. Cryer PE, Tse TF, Clutter WE, Shah SD. Roles of glucagon and epinephrine in hypoglycemic and nonhypoglycemic glucose counter-regulation in humans. Am J Physiol. 1984;247(2 Pt 1):E198-205. (Pubitemid 14064253)
46. Biourge V, Nelson RW, Feldman EC, Willits NH, Morris JG, Rogers QR. Effect of weight gain and subsequent weight loss on glucose tolerance and insulin response in healthy cats. J Vet Intern Med. 1997;11(2):86-91.
47. Hoenig M, Alexander S, Holson J, Ferguson DC. Influence of glucose dosage on interpretation of intravenous glucose tolerance tests in lean and obese cats. J Vet Intern Med. 2002;16(5):529-32. (Pubitemid 135747430)
48. O'Brien TD, Hayden DW, Johnson KH, Stevens JB. High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis. Vet Pathol. 1985;22(3):250-61.
49. Nelson RW, Himsel CA, Feldman EC, Bottoms GD. Glucose tolerance and insulin response in normal-weight and obese cats. Am J Vet Res. 1990;51(9):1357-62. (Pubitemid 20326493)
50. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9. (Pubitemid 15018832)
51. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402-10. (Pubitemid 32269192)
52. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294(1):E15-26.
53. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487-95. (Pubitemid 38680001)
54. Stefanovski D, Ader M, Richey JM, Kim SP, Woolcott O, Harrison LN, Kolka CM, Ionut V, Dittmann J, Yae S, Catalano KJ, Hsu IR, Mooradian V, Chiu JD, Castro AV, Zheng D, Lottati M, Kabir M, Liu H, Bergman RN. Failure of homeostatic model assessment of insulin resistance (HOMA-IR) to detect marked diet-induced insulin resistance in dogs. Abstract 1535. 71st Meeting of the American Diabetes Association, San Diego, California, 2011.
55. Slingerland LI, Robben JH, van Haeften TW, Kooistra HS, Rijnberk A. Insulin sensitivity and beta-cell function in healthy cats: assessment with the use of the hyperglycemic glucose clamp. Horm Metab Res. 2007;39(5):341-6. (Pubitemid 46877849)
56. Elahi D. In praise of the hyperglycemic clamp. A method for assessment of beta-cell sensitivity and insulin resistance. Diabetes Care. 1996;19(3):278-86. (Pubitemid 26070357)
57. Vilsbøll T, Holst JJ. Incretins, insulin secretion and type 2 diabetes mellitus. Diabetologia. 2004;47(3):357-66. (Pubitemid 38491230)
58. Opitz M. Stress hyperglycemia in cats. Berl Munch Tierarztl Wochenschr. 1990;103(5):151-8.
59. Hoenig M, Jordan ET, Ferguson DC, de Vries F. Oral glucose leads to a diferential response in glucose, insulin, and GLP-1 in lean versus obese cats. Domest Anim Endocrinol. 2010;38(2):95-102.
60. Church DB. A comparison of intravenous and oral glucose tolerance tests in the dog. Res Vet Sci. 1980;29(3):353-9. (Pubitemid 11160124)
61. Hoenig M, Pach N, Thomaseth K, de Vries F, Ferguson DC. Evaluation of long-term glucose homeostasis in lean and obese cats using continuous glucose monitoring. Am J Vet Res. Forthcoming.
62. Schindler C. The metabolic syndrome as an endocrine disease: is there an efective pharmacotherapeutic strategy optimally targeting the pathogenesis? Ther Adv Cardiovasc Dis. 2007;1(1):7-26.
63. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol. 1998;18(7):1046-53. (Pubitemid 28323588)
64. Gof DC Jr, D'Agostino RB Jr, Hafner SM, Otvos JD. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. results from the insulin resistance atherosclerosis study. Metabolism. 2005;54(2):264-70. (Pubitemid 40174857)
65. Grifin BA. Lipoprotein atherogenicity: an overview of current mechanisms. Proc Nutr Soc. 1999;58(1):163-9.
66. Li P, Zhu Z, Lu Y, Granneman JG. Metabolic and cellular plasticity in white adipose tissue II: role of peroxisome proliferator-activated receptor-alpha. Am J Physiol Endocrinol Metab. 2005;289(4):E617-26. (Pubitemid 41356083)
67. Hoenig M, Cafall Z, Ferguson DC. Triiodothyronine diferentially regulates key metabolic factors in lean and obese cats. Domest Anim Endocrinol. 2008;34(3):229-37. (Pubitemid 351335201)
68. Hafner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229-34. (Pubitemid 28350165)
69. Mahley RW, Ji ZS. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res. 1999;40(1):1-16. (Pubitemid 29022581)
70. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. prospective results from the quebec cardiovascular study. Circulation. 1997;95(1):69-75. (Pubitemid 27029945)
71. Blake GJ, Otvos JD, Rifai N, Ridker PM. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation. 2002;106(15):1930-7. (Pubitemid 35176297)
72. Jordan E, Kley S, Le NA, Waldron M, Hoenig M. Dyslipidemia in obese cats. Domest Anim Endocrinol. 2008;35(3):290-9.
73. Arsenault BJ, Lemieux I, Després JP, Gagnon P, Wareham NJ, Stroes ES, Kastelein JJ, Khaw KT, Boekholdt SM. HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-norfolk prospective population study. Atherosclerosis. 2009;206(1):276-81.
74. Ishioka K, Omachi A, Sasaki N, Kimura K, Saito M. Feline adiponectin: molecular structures and plasma concentrations in obese cats. J Vet Med Sci. 2009;71(2):189-94.
75. Backus RC, Havel PJ, Gingerich RL, Rogers QR. Relationship between serum leptin immunoreactivity and body fat mass as estimated by use of a novel gas-phase Fourier transform infrared spectroscopy deuterium dilution method in cats. Am J Vet Res. 2000;61(7):796-801.
76. Shibata H, Sasaki N, Honjoh T, Ohishi I, Takiguchi M, Ishioka K, Ahmed M, Soliman M, Kimura K, Saito M. Feline leptin: immunogenic and biological activities of the recombinant protein, and its measurement by ELISA. J Vet Med Sci. 2003;65(11):1207-11. (Pubitemid 41380045)
77. Ahima RS. Metabolic actions of adipocyte hormones: focus on adiponectin. Obesity (Silver Spring). 2006;14 Suppl 1:9S-15S.
78. Ahima RS, Flier JS. Leptin. Annu Rev Physiol. 2000;62:413-37. (Pubitemid 30618269)
79. Ferguson DC, Cafall Z, Hoenig M. Obesity increases free thyroxine proportionally to nonesterified fatty acid concentrations in adult neutered female cats. J Endocrinol. 2007;194(2):267-73. (Pubitemid 47249665)